Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, works by slowing stomach emptying and activating appetite-suppression pathways in the brain, leading to meaningful weight reduction for many patients. Understanding realistic weight loss expectations helps you set achievable goals and stay motivated throughout your treatment journey. PlexusDx offers compounded semaglutide injections starting at $149 per month, giving you access to the same mechanism as Wegovy without the brand markup.

Average Weight Loss with Semaglutide Injections

The STEP trials, which tested semaglutide for weight management, found that participants receiving weekly injections lost an average of 15.3 kilograms, or roughly 34 pounds, over 68 weeks of treatment. Higher-dose groups in the same studies achieved average weight loss of 17.4 kilograms (38 pounds), representing approximately 15% to 22% of starting body weight. These results significantly outperformed placebo, where participants lost only 2.6 kilograms on average. Individual outcomes vary based on starting weight, metabolism, lifestyle changes, and genetic predispositions affecting how your body responds to GLP-1 receptor activation.

Weight loss typically follows a predictable timeline, with initial results visible within the first two to four weeks as appetite decreases and food intake naturally reduces. The most dramatic weight reductions usually occur between months two and six, when your body has adapted to the medication and behavioral changes have become more sustainable. After month six, the rate of weight loss typically slows but continues steadily through month 12 and beyond with consistent treatment adherence. PlexusDx patients using compounded semaglutide report similar patterns, supported by dose optimization and personalized treatment monitoring.

Factors That Influence Your Personal Weight Loss Results

Your genetic makeup plays a significant role in how much weight semaglutide helps you lose, particularly variants in genes controlling GLP-1 receptor function, GIPR signaling, and appetite regulation pathways. The PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides, including key variants like GLP1R rs6923761 and MC4R rs17782313, to predict your likely response to semaglutide therapy. Patients carrying certain protective variants often experience faster initial weight loss and better long-term adherence, while those with metabolically challenging variants may need higher doses or combination therapy to achieve similar results.

Behavioral factors including dietary quality, physical activity level, sleep duration, and stress management directly impact weight loss outcomes alongside medication. Individuals who combine semaglutide with modest caloric restriction and regular movement typically lose 5% to 10% more weight than those relying on the injection alone. Your baseline metabolism, age, hormonal status, and any underlying metabolic conditions also shape the speed and magnitude of weight reduction. PlexusDx's personalized approach considers all these variables to optimize your dosing and treatment strategy for maximum sustainable results.

How Semaglutide Dosing Affects Weight Loss Outcomes

Semaglutide treatment begins with a low weekly dose of 0.25 milligrams, which gradually increases over 16 weeks to reach a maintenance dose of 2.4 milligrams weekly in most patients. The gradual titration schedule minimizes gastrointestinal side effects while allowing your body to adapt to the medication's hunger-suppressing effects. Some individuals achieve optimal weight loss at the 1.7 milligram maintenance dose, while others benefit from reaching the full 2.4 milligram dose, with response depending partly on your genetic peptide pathways. PlexusDx pricing remains flat at $149 per month throughout your entire treatment journey—your dose may need to go up, but your price won't increase as you optimize therapy.

Maintaining Weight Loss After You Stop Semaglutide Treatment

Research shows that weight regain occurs in many patients who discontinue semaglutide, with some studies finding that roughly two-thirds of lost weight returns within one year after stopping the medication. This rebound happens because appetite-regulation pathways return to their pre-treatment set point once the medication leaves your system, typically within two to four weeks. The most successful long-term outcomes occur in patients who maintain semaglutide treatment indefinitely, similar to how blood pressure medications require ongoing use to sustain benefits.

Building lasting lifestyle habits during your time on semaglutide—including consistent physical activity, protein-rich eating patterns, and stress management—helps minimize rebound weight gain if you eventually discontinue treatment. Some patients transition to lower maintenance doses rather than stopping entirely, preserving most weight loss while reducing medication costs. PlexusDx supports long-term treatment planning with compounded semaglutide injections available month-to-month without membership fees or insurance requirements, making extended therapy accessible and affordable for weight loss maintenance.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight did people lose in the Wegovy clinical trials?

STEP trial participants receiving semaglutide injections lost 15.3 to 17.4 kilograms (34 to 38 pounds) over 68 weeks, representing 15% to 22% of body weight, compared to 2.6 kilograms in the placebo group. Results varied based on individual genetics, starting weight, and adherence to lifestyle modifications alongside medication.

When do you see weight loss results from semaglutide?

Most patients notice appetite reduction and initial weight loss within two to four weeks of starting semaglutide treatment. Peak weight loss velocity typically occurs between months two and six, with results continuing more gradually through month 12 and beyond as long as you remain on the medication.

Does PlexusDx compounded semaglutide work the same as Wegovy?

Yes, PlexusDx compounded semaglutide contains the identical active ingredient as Wegovy and operates through the same biological mechanisms. The difference is that PlexusDx uses licensed 503A compounding pharmacies to prepare your injections, offering the same clinical benefits at a lower cost starting at $149 per month without insurance requirements.

Can genetics affect how much weight I'll lose with semaglutide?

Your genetic variants in GLP-1 receptor, GIPR, FTO, and MC4R genes significantly influence how your body responds to semaglutide therapy. The PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes these pathways across 14 metabolic systems to predict your likely weight loss response and help optimize your personalized treatment dose.

What happens to weight loss if you stop taking semaglutide?

Roughly two-thirds of weight loss returns within one year after stopping semaglutide, as appetite-regulating pathways revert to their pre-treatment baseline. Many patients choose to continue treatment indefinitely or use lower maintenance doses to sustain results, with PlexusDx offering affordable month-to-month access without membership commitments.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves